超基因组学和个性化医学
Herbert W Virgin1, John A Todd
1Department of Pathology and Immunology, Midwest Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research, Washington University School of Medicine, St. Louis, MO 63110, USA. virgin@wustl.edu
Cell
|October 4, 2011
概括
人类微生物组影响疾病易感性,特别是炎症性疾病. 了解宿主-基因-微生物相互作用是开发复杂疾病个性化治疗的关键.
科学领域:
- 人类微生物组研究研究
- 遗传学和疾病病因学
- 免疫学和炎症 免疫学和炎症
背景情况:
- 人类微生物群,包括各种微生物,显著影响健康和疾病.
- 它在调节宿主免疫力和对1型糖尿病,性结肠炎和克罗恩病等炎症性疾病的易感性方面发挥着至关重要的作用.
- 主体-基因-微生物相互作用是多因素慢性疾病的发展的核心.
研究的目的:
- 阐明宿主基因-微生物相互作用在慢性炎症疾病中的作用.
- 探索全基因组关联研究 (GWAS) 如何识别疾病亚型.
- 促进对复杂疾病病因学的理解,并为治疗策略提供信息.
主要方法:
- 对微生物组,宿主遗传学和炎症性疾病的当前研究进行审查和综合.
- 在自身免疫和炎症性疾病中对全基因组关联研究 (GWAS) 的发现进行分析.
- 开发概念框架,以了解疾病中的基因型-表型关系.
主要成果:
- 宿主基因-微生物相互作用被确定为多因素慢性疾病的关键决定因素.
- GWAS正在揭示基于机制的自身免疫和炎症性疾病的亚型.
- 新兴的概念将遗传倾向与微生物对疾病表型的影响联系起来.
结论:
- 对宿主-基因-微生物相互作用的全面理解对于破译复杂疾病病因至关重要.
- 这些知识将有助于开发先进的动物模型.
- 可以开发针对特定疾病表型的个性化治疗策略.
相关概念视频
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Genomics
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...

